Schizophrenia patients' and psychiatrists' perspectives on ethical aspects of symptom re-emergence during psychopharmacological research participation

Psychopharmacology

Volumn 171, Issue 1, 2003, Pages 58-67

  Roberts, Laura Weiss ^a   Warner, Teddy D ^a   Nguyen, Khanh P ^a   Geppert, Cynthia M A ^a   Rogers, Melinda K ^a   Roberts, Brian B ^b,c  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b VA Medical Center   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Ethics; Psychiatry; Research; Schizophrenia; Wash out

Indexed keywords

CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL RESEARCH; DECISION MAKING; HOSPITAL DISCHARGE; HUMAN; HYPOTHESIS; MEDICAL ETHICS; MENTAL PATIENT; MONEY; PREDICTION; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOPHARMACOLOGY; QUESTIONNAIRE; RECURRENT DISEASE; REVIEW; STATISTICAL ANALYSIS;

ADULT; ATTITUDE; ATTITUDE OF HEALTH PERSONNEL; CLINICAL TRIALS; FEMALE; HOSPITALIZATION; HUMAN EXPERIMENTATION; HUMANS; MALE; PATIENT RIGHTS; PHYSICIANS; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 1642537720     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1160-9     Document Type: Review

References (16)

1. American Psychiatric Association (2000) Group rejects placebos in most clinical trials. In: Psychiatric news. APA, Washington, DC. http://www.psych. org/pnews/00-11-17/group.html
2. Appelbaum P (1996) Drug-free research in schizophrenia: an overview of the controversy. IRB 18:1-5
3. Carpenter W, Schooler N, Kane J (1997) The rationale and ethics of medication-free research in schizophrenia. Arch Gen Psychiatry 54:401-407
4. Emanuel EJ, Miller FG (2001) The ethics of placebo-controlled trials-a middle ground. New Engl J Med 345:915-919
5. Hyman SE, Shore D (2000) An NIMH perspective on the use of placebos. National Institute of Mental Health. Biol Psychiatry 47:689-691
6. Lieberman J, Stroup S, Laska W, Volavka J, Gelenberg A, Rush J, Shear K, Carpenter W (1999) Issues in clinical research design: principles, practices, and controversy. In: Pincus H, Lieberman J, Ferris S (eds) Ethics in psychiatric research. A resource manual for human subjects protections. American Psychiatric Association, Washington, DC
7. Pincus H, Lieberman J, Ferris S (eds) (1999) Ethics in psychiatric research: a resource manual for human subjects protection, 1st edn. American Psychiatric Association, American Psychiatric Association
8. President's Advisory Committee on Human Radiation Experiments (1996) The human radiation experiments: final report of the President's Advisory Committee. Oxford University Press, Oxford University Press. http://tis.eh.doe.gov/ohre/ roadmap/ achre/report.html
9. Roberts LW (1999) Ethical dimensions of psychiatric research: a constructive, criterion-based approach to protocol preparation. The research protocol ethics assessment tool (RePEAT). Biol Psychiatry 46:1106-1119
10. Roberts LW, Warner TD, Brody JL (2000) Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation. Am J Psychiatry 157:67-74
11. Roberts LW, Warner TD, Brody J, Roberts B, Lauriello J, Lyketsos C (2002) Research harm assessments and participation decisions and schizophrenia patients and psychiatrists. Am J Psychiatry 159:573-584
12. Rothman KJ, Michels KB (1994) The continuing unethical use of placebo controls. New Engl J Med 331:394-398
13. Shamoo A (1997) Ethics in neurobiological research with human subjects. Gordon and Breach, New York
14. Shore D, Hyman SE (1999) An NIMH commentary on the NBAC report. Biol Psychiatry 46:1013-1016
15. World Medical Association General Assembly (2001) Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 79:373-374. http:// www.wma.net/e/policy/17-c_e.html
16. Yuwiler A, Wetterberg L (2000) Methodology guide to psychiatric research. CRC Press, Boca Raton, FL, pp 49